BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 11657410)

  • 1. Paying people to give up their organs: the problem with commodification of body parts.
    Stempsey WE
    Med Humanit Rev; 1996; 10(2):45-55. PubMed ID: 11657410
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulated commercialism of vital organ donation: a necessity? Con.
    Fox RC
    Transplant Proc; 1993 Feb; 25(1):55-7. PubMed ID: 11655154
    [No Abstract]   [Full Text] [Related]  

  • 3. The economics and ethics of alternative cadaveric organ procurement policies.
    Blair RD; Kaserman DL
    Yale J Regul; 1991; 8(2):403-52. PubMed ID: 11652066
    [No Abstract]   [Full Text] [Related]  

  • 4. Am I my brother's keeper?
    Caplan AL
    Suffolk Univ Law Rev; 1993; 27(4):1195-208. PubMed ID: 11657034
    [No Abstract]   [Full Text] [Related]  

  • 5. Homo economicus: commercialization of body tissue in the age of biotechnology.
    Nelkin D; Andrews L
    Hastings Cent Rep; 1998; 28(5):30-9. PubMed ID: 11656768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The body as property: some philosophical reflections -- a response to J.F. Childress.
    Andrews LB
    Transplant Proc; 1992 Oct; 24(5):2149-51. PubMed ID: 11643030
    [No Abstract]   [Full Text] [Related]  

  • 7. Consent for organ donation: what are the ethical principles?
    Sells RA
    Transplant Proc; 1993 Feb; 25(1):39-41. PubMed ID: 11655153
    [No Abstract]   [Full Text] [Related]  

  • 8. Whose tissues are they anyway? A proposal for state ownership of the human body and its parts.
    Schoenfeld MR
    J Cardiovasc Diagn Proced; 1994-1995; 12(3):145-9. PubMed ID: 11654296
    [No Abstract]   [Full Text] [Related]  

  • 9. Yes, let's pay for organs.
    Krauthammer C
    Time; 1999 May; 153(19):100. PubMed ID: 11645351
    [No Abstract]   [Full Text] [Related]  

  • 10. Commerce in human organs: a global review.
    Sells RA
    Dial Transplant; 1990 Jan; 19(1):10, 17. PubMed ID: 11651019
    [No Abstract]   [Full Text] [Related]  

  • 11. Transplantation and commercial gain.
    Castro JE; Starkman B
    Lancet; 1985 Dec 21-28; 2(8469-8470):1429. PubMed ID: 11658650
    [No Abstract]   [Full Text] [Related]  

  • 12. The morality of a free market for transplant organs.
    Nelson MT
    Public Aff Q; 1991 Jan; 5(1):63-79. PubMed ID: 11652012
    [No Abstract]   [Full Text] [Related]  

  • 13. A commercial market for organs? Why not?
    Manga P
    Bioethics; 1987 Oct; 1(4):321-38. PubMed ID: 11651906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tax consequences of selling human organs.
    Borna S; Foss HB
    Akron Bus Econ Rev; 1986; 17(3):55-60. PubMed ID: 11649822
    [No Abstract]   [Full Text] [Related]  

  • 15. Second thoughts about body parts.
    Meilaender G
    First Things; 1996 Apr; No. 62():32-7. PubMed ID: 11656520
    [No Abstract]   [Full Text] [Related]  

  • 16. The meaning of "The economics and ethics of alternative cadaveric organ procurement policies.
    Guttmann RD
    Yale J Regul; 1991; 8(2):453-62. PubMed ID: 11652067
    [No Abstract]   [Full Text] [Related]  

  • 17. The sale of human body parts.
    Mich Law Rev; 1974 May; 72(6):1182-264. PubMed ID: 11664350
    [No Abstract]   [Full Text] [Related]  

  • 18. Body parts for sale.
    Gorman C
    Time; 1998 Mar; 151(9):76. PubMed ID: 11655275
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporine as an ethical catalyst: recent issues in kidney transplantation.
    Morden M
    Public Aff Q; 1988 Oct; 2(4):31-45. PubMed ID: 11659054
    [No Abstract]   [Full Text] [Related]  

  • 20. Increasing the supply of transplant organs: the virtues of a futures market.
    Cohen LR
    George Washington Law Rev; 1989 Nov; 58(1):1-51. PubMed ID: 11656012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.